COLLEEN COLEMAN-SPICIATI: Open Payments
NPI 1659318947 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 34 payments from 9 companies in 2025. Trend: 2023 $42 · 2024 $336 · 2025 $891
Food & beverage: $891
| Company | Payments | Amount |
|---|---|---|
| Indivior Inc. | 9 | $242 |
| Braeburn Inc. | 4 | $197 |
| Alkermes, Inc. | 5 | $119 |
| Otsuka America Pharmaceutical, Inc. | 5 | $105 |
| Janssen Pharmaceuticals, Inc | 3 | $98 |
| Teva Pharmaceuticals USA, Inc. | 3 | $48 |
| ABBVIE INC. | 3 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| Orexo US, Inc. | 1 | $19 |
Products named: SUBLOCADE, BRIXADI, VIVITROL, SPRAVATO, REXULTI, ABILIFY MAINTENA, UZEDY, MAVYRET.
Industry payments across NY — which companies pay providers there.
